Cooperative dimerization of a heterocyclic diamidine determines sequence-specific DNA recognition.
In the course of a program aimed at discovering novel DNA-targeted antiparasitic drugs, the phenylfuran-benzimidazole unfused aromatic dication DB293 was identified as the first diamidine capable of forming stacked dimers in the DNA minor groove of GC-containing sequences. Its preferred binding sequence encompasses the tetranucleotide 5'-ATGA.5'-TCAT to which DB293 binds tightly with a strong positive cooperativity. Here we have investigated the influence of the DNA sequence on drug binding using two complementary technical approaches: surface plasmon resonance and DNase I footprinting. The central dinucleotide of the primary ATGA motif was systematically varied to represent all of the eight possible combinations (AXGA and ATYA, where X or Y = A, T, G, or C). Binding affinities for each site were precisely measured by SPR, and the extent of cooperative drug binding was also determined. The sequence recognition process was found to be extremely dependent on the nature of the central dinucleotide pair. Modification of the central TG step decreases binding affinity by a factor varying from 2 to over 500 depending on the base substitution. However, the diminished binding affinity does not affect the unique binding mode. In nearly all cases, the SPR titrations revealed a positive cooperativity in complex formation which reflects the ease of the dication to form stacked dimeric motifs in the DNA minor groove. DNase I footprinting served to identify additional binding sites for DB293 in the context of long DNA sequences offering a large variety of randomly distributed or specifically designed sites. The ATGA motif provided the best receptor for the drug, but lower affinity sequences were also identified. The design of two DNA fragments composed of various targeted tetranucleotide binding sites separated by an "insulator" (nonbinding) sequence allowed us to delineate further the influence of DNA sequence on drug binding and to identify a novel high-affinity site: 5'-ACAA.5'-TTGT. Collectively, the SPR and footprinting results show that the consensus sequence 5'-(A/T)-TG-(A/T) represents the optimal site for cooperative dimerization of the heterocyclic diamidine DB293.
Tanious
Farial
F
Department of Chemistry and Laboratory for Chemical and Biological Sciences, Georgia State University, Atlanta, Georgia 30303, USA.
Wilson
W David
WD
Wang
Lei
L
Kumar
Arvind
A
Boykin
David W
DW
Marty
Carine
C
Baldeyrou
Brigitte
B
Bailly
Christian
C
D001483:Base Sequence; D001550:Benzamidines / Q000737:chemistry* / Q000378:metabolism*; D001562:Benzimidazoles / Q000737:chemistry* / Q000378:metabolism*; D001665:Binding Sites; D001710:Biotin / Q000737:chemistry; D004247:DNA / Q000737:chemistry* / Q000378:metabolism*; D018983:DNA Footprinting; D003850:Deoxyribonuclease I / Q000378:metabolism; D019281:Dimerization; D015195:Drug Design; D005663:Furans / Q000737:chemistry* / Q000378:metabolism*; D007700:Kinetics; D009690:Nucleic Acid Conformation; D009841:Oligonucleotides / Q000235:genetics; D020349:Surface Plasmon Resonance
D001550:Benzamidines; D001562:Benzimidazoles; C480104:DB293; D005663:Furans; D009841:Oligonucleotides; D001710:Biotin; D004247:DNA; D003850:Deoxyribonuclease I